Evidence map›Paper›PMID 15972108›Full record

ReviewRespiratory research2005

Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator.

Argyris Tzouvelekis, Ioannis Pneumatikos, Demosthenes Bouros

Registry-linked trialAbstract readReview
In one paragraph

Review in Respiratory research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00989846 (Feasibility Study on Establishing Biomarkers in Lung Diseases), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00989846 unknown statusnot on this mapstarted 2009, after this paper: background citation

Feasibility Study on Establishing Biomarkers in Lung Diseases

TypeobservationalSponsorHeidelberg UniversityRan2009 to 2010Enrolled120ConditionsLung DiseasesArmsbiomarker
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Acute lung failure.Seminars in respiratory and critical care medicine · 2011
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Argyris TzouvelekisRoyal Brompton Hospital, Faculty of Medicine, Imperial College, London, UK. atzouvelekis@yahoo.gr
Ioannis Pneumatikos
Demosthenes Bouros

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of biomarkers in medicine lies in their ability to detect disease and support diagnostic and therapeutic decisions. New research and novel understanding of the molecular basis of the disease reveals an abundance of exciting new biomarkers who present a promise for use in the everyday clinical practice. The past fifteen years have seen the emergence of numerous clinical applications of several new molecules as biologic markers in the research field relevant to acute respiratory distress syndrome (translational research). The scope of this review is to summarize the current state of knowledge about serum biomarkers in acute lung injury and acute respiratory distress syndrome and their potential value as prognostic tools and present some of the future perspectives and challenges.

Indexed as

AnimalsBiomarkersBlood ProteinsHumansPrognosisRespiratory Distress SyndromeRisk AssessmentRisk FactorsBiomarkersBlood Proteins

Identifiers

PMID15972108
PMCPMC1168906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.